June 26, 2019
A Pennsylvania federal judge nixed claims Wednesday that McKesson Corp. earned billions of dollars by cooperating with an industry-wide price-fixing conspiracy among generic-drug makers, ruling that a putative class' allegations in the multidistrict litigation are impermissible suppositions.
February 22, 2019
More than two dozen generic-drug companies have asked a Pennsylvania federal court to carve out allegations of an "overarching conspiracy" from sprawling multidistrict litigation brought by state attorneys general and private plaintiffs, arguing the price-fixing allegations fall short of asserting a single industrywide scheme.
September 26, 2018
McKesson Corp. earned billions of dollars by cooperating with an industrywide price-fixing conspiracy among generic-drug makers, according to a proposed class action Tuesday that appeared to be one of the first suits linking a drug distributor to multidistrict litigation over alleged drugmaker collusion.